According to the recent study the needle-free injection system market is projected to reach an estimated $6.4 billion by 2027 from $2.7 billion in 2021, at a CAGR of 15.7% from 2021 to 2027. Growth in this market is primarily driven by growing prevalence of chronic diseases, the increasing incidence of communicable diseases due to needle stick injuries, and rise in demand for self-injection devices.
Browse 153 figures / charts and 145 tables in this 290 -page report to understand trends, opportunities and forecast in needle-free injection system market by product (fillable needle-free injectors and prefilled needle-free injectors), technology (jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors), usability (reusable and disposable needle-free injectors), type of medication (liquid-based needle-free injectors, powder-based needle-free injectors, and projectile/depot-based needle-free injectors), site of delivery (intradermal injectors, intramuscular injectors, and subcutaneous injectors), application (vaccine needle-free delivery, insulin needle-free delivery, pain management needle-free delivery, oncology needle-free delivery, and others), end users (hospitals and clinics, homecare settings, research laboratories, pharmaceutical and biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Download sample report by clicking on below link https://www.lucintel.com/needle-free-injection-system-market.aspx

“Jet-based needle-free injector market is expected to remain the largest segment during the forecast period.”
Based on technology, the needle-free injection system market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, laser-powered needle-free injectors, and vibration-based needle-free injectors. Lucintel forecasts that the jet-based needle-free injector market is expected to remain the largest segment accounted for the largest share as it helps in preventing needlestick injuries to healthcare providers and overcomes the drawbacks of improper and unsterile reuse of needles & syringes.
“Within the needle-free injection system market, the prefilled needle-free injectors segment is expected to remain the largest product”
Based on product the prefilled needle-free injectors segment is expected to witness the highest growth over the forecast period due to the majority of these prefilled syringes are automated and thus reducing the risk of physical handling and ensuring a safer use.
“North America will dominate the needle-free injection system market in near future”
North America is expected to remain the largest market during the forecast period mainly due growing prevalence of chronic disease and rising demand for self-injection systems contribute to North America driving the market. APAC is likely to witness the highest growth over the forecast period due to the expansion of private-sector hospitals and clinics to rural areas, the availability of low-cost labor for manufacturing.
Download Brochure of this report by clicking on https://www.lucintel.com/needle-free-injection-system-market.aspx
Major players of needle-free injection system market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Endo International plc, Ferring Pharmaceuticals, Penjet Corporation, Medical International Technology Inc., PharmaJet are among the major needle-free injection system providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/needle-free-injection-system-market.aspx or [email protected]